Qiuqing Wang

2.7k total citations · 3 hit papers
15 papers, 854 citations indexed

About

Qiuqing Wang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, Qiuqing Wang has authored 15 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 3 papers in Pharmacology. Recurrent topics in Qiuqing Wang's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Cardiac Structural Anomalies and Repair (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Qiuqing Wang is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Cardiac Structural Anomalies and Repair (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Qiuqing Wang collaborates with scholars based in United States, Australia and United Kingdom. Qiuqing Wang's co-authors include Peter Dy, Pallavi Bhattaram, Véronique Lefebvre, Weihuan Wang, R. Tracy Ballock, Lai Wang, Kathy Wolski, Milind Y. Desai, Divyang Patel and Barbara Bittel and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nucleic Acids Research.

In The Last Decade

Qiuqing Wang

13 papers receiving 845 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection

2021 240 citations Divyang Patel, Barbara Bittel et al. JAMA Network Open profile →
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)

2024 49 citations Steven E. Nissen, Qiuqing Wang et al. JAMA profile →
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)

2025 27 citations Steven E. Nissen, Wei Ni et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Qiuqing Wang

Since Specialization

Citations

This map shows the geographic impact of Qiuqing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuqing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuqing Wang more than expected).

Fields of papers citing papers by Qiuqing Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuqing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuqing Wang. The network helps show where Qiuqing Wang may publish in the future.

Co-authorship network of co-authors of Qiuqing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuqing Wang. A scholar is included among the top collaborators of Qiuqing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuqing Wang. Qiuqing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a) breakdown → 2025 ·New England Journal of Medicine ·Steven E. Nissen, Wei Ni, Xi Shen, Qiuqing Wang, Ann Marie Návar, Stephen J. Nicholls, Kathy Wolski, (unknown), Axel Haupt, John H. Krege	27
2	Long-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for Up to 128 Weeks 2025 ·JACC. Cardiovascular imaging ·Milind Y. Desai, (unknown), Kathy Wolski, Jeffrey B. Geske, Anjali Owens, Qiuqing Wang, Sara Saberi, (unknown), Paul Cremer, Neal K. Lakdawala, Mark V. Sherrid, Albree Tower‐Rader, David Fermin, (unknown), Srihari S. Naidu, Kathy Lampl, Steven E. Nissen, Zoran V. Popović, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
3	Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 2025 ·New England Journal of Medicine ·Luke J. Laffin, Stephen J. Nicholls, Russell Scott, Peter Clifton, John E. Baker, Ashish Sarraju, Shweta Singh, Qiuqing Wang, Kathy Wolski, Huansheng Xu, (unknown), Nipam H. Patel, Jason M. Duran, Steven E. Nissen	3
4	Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a) breakdown → 2024 ·JAMA ·Steven E. Nissen, Qiuqing Wang, Stephen J. Nicholls, Ann Marie Návar, Kausik K. Ray, Gregory G. Schwartz, Michael Szarek, (unknown), Roland P.T. Troquay, Jannick A N Dorresteijn, Henry Fok, David A. Rider, Steven J. Romano, Kathy Wolski, Curtis Rambaran	49
5	Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation 2023 ·Circulation ·Samir Kapadia, Amar Krishnaswamy, Brian Whisenant, Srinivasa Potluri, Vijay Iyer, Joseph Aragon, (unknown), (unknown), Robert A. Leonardi, Himanshu Agarwal, Germán Larrain, Carlos E. Sanchez, Sidakpal Panaich, James E. Harvey, Torsten Vahl, Venu Menon, Kathy Wolski, Qiuqing Wang, Martin B. Leon	18
6	Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial 2022 ·European Heart Journal - Cardiovascular Pharmacotherapy ·(unknown), Peter Libby, M. Elaine Husni, Qiuqing Wang, L Wiśniewski, Deborah Davey, Katherine E. Wolski, Feng Xia, Weihang Bao, Chris Walker, Frank Ruschitzka, Steven E. Nissen, Thomas F. Lüscher	22
7	Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study 2022 ·Circulation Cardiovascular Imaging ·Paul Cremer, Jeffrey B. Geske, Anjali Owens, Wael A. Jaber, Serge C. Harb, Sara Saberi, Andrew Wang, Mark V. Sherrid, Srihari S. Naidu, Hartzell V. Schaff, Nicholas G. Smedira, Qiuqing Wang, Kathy Wolski, Kathy Lampl, Amy J. Sehnert, Steven E. Nissen, Milind Y. Desai	41
8	Dynamic Assessment of Pulmonary Artery Pulsatility Index Provides Incremental Risk Assessment for Early Right Ventricular Failure After Left Ventricular Assist Device 2021 ·Journal of Cardiac Failure ·(unknown), Qiuqing Wang, Dmitry Yaranov, (unknown), Kathy Wolski, (unknown), (unknown), Venu Menon, Miriam Jacob, W.H. Wilson Tang, Eileen Hsich, David Taylor, Michael Z. Tong, Edward G. Soltesz, Jerry D. Estep, Randall C. Starling, Emer Joyce	21
9	Postimplant Phosphodiesterase-5 Inhibitor Use in Centrifugal Flow Left Ventricular Assist Devices 2021 ·JACC Heart Failure ·Αndrew Xanthopoulos, Kathy Wolski, Qiuqing Wang, Eugene H. Blackstone, Varinder K. Randhawa, Edward G. Soltesz, James B. Young, Steven E. Nissen, Jerry D. Estep, Filippos Triposkiadis, Randall C. Starling	16
10	Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection breakdown → 2021 ·JAMA Network Open ·(unknown), Divyang Patel, Barbara Bittel, Kathy Wolski, Qiuqing Wang, Anirudh Kumar, Zachary J. Il’Giovine, Reena Mehra, Carla McWilliams, S.E. Nissen, Milind Y. Desai	240
11	The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial 2018 ·Lara D. Veeken ·Daniel H. Solomon, Peter Libby, Neville D. Yeomans, Qiuqing Wang, Kathy Wolski, Steven E. Nissen, M. Elaine Husni	5
12	Gastrointestinal Events in Arthritis Patients at Increased Cardiovascular Risk Treated Chronically with Celecoxib, Naproxen or Ibuprofen: The Precision Randomized Controlled Trial 2017 ·Gastroenterology ·Neville D. Yeomans, David Y. Graham, M. Elaine Husni, Daniel H. Solomon, Tyler Stevens, John J. Vargo, Qiuqing Wang, L Wiśniewski, Katherine E. Wolski, Steven E. Nissen	0
13	Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis 2017 ·Arthritis & Rheumatology ·Daniel H. Solomon, M. Elaine Husni, Katherine E. Wolski, L Wiśniewski, Jeffrey Borer, David Y. Graham, Peter Libby, A. Michael Lincoff, Thomas F. Lüscher, Venu Menon, Neville D. Yeomans, Qiuqing Wang, Weihang Bao, Manuela Berger, Steven E. Nissen, (unknown)	39
14	A far-upstream (−70 kb) enhancer mediates Sox9 auto-regulation in somatic tissues during development and adult regeneration 2013 ·Nucleic Acids Research ·Timothy J. Mead, Qiuqing Wang, Pallavi Bhattaram, Peter Dy, Solomon Afelik, Jan Jensen, Véronique Lefebvre	71
15	Sox9 Directs Hypertrophic Maturation and Blocks Osteoblast Differentiation of Growth Plate Chondrocytes 2012 ·Developmental Cell ·Peter Dy, Weihuan Wang, Pallavi Bhattaram, Qiuqing Wang, Lai Wang, R. Tracy Ballock, Véronique Lefebvre	302

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact